PL2182966T3 - Zastosowanie ekstraktów lub substancji ekstrahowanych z Piper cubeba L. jako składników czynnych leku do leczenia chorób nowotworowych - Google Patents

Zastosowanie ekstraktów lub substancji ekstrahowanych z Piper cubeba L. jako składników czynnych leku do leczenia chorób nowotworowych

Info

Publication number
PL2182966T3
PL2182966T3 PL08783450T PL08783450T PL2182966T3 PL 2182966 T3 PL2182966 T3 PL 2182966T3 PL 08783450 T PL08783450 T PL 08783450T PL 08783450 T PL08783450 T PL 08783450T PL 2182966 T3 PL2182966 T3 PL 2182966T3
Authority
PL
Poland
Prior art keywords
extracts
drug
treatment
effective component
cancer diseases
Prior art date
Application number
PL08783450T
Other languages
English (en)
Inventor
Matthias-Heinrich Kreuter
Jian Ying Yam
Karin Berger-Büter
Original Assignee
Viridis Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viridis Pharmaceutical Ltd filed Critical Viridis Pharmaceutical Ltd
Publication of PL2182966T3 publication Critical patent/PL2182966T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL08783450T 2007-08-16 2008-08-15 Zastosowanie ekstraktów lub substancji ekstrahowanych z Piper cubeba L. jako składników czynnych leku do leczenia chorób nowotworowych PL2182966T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH01289/07A CH698627B1 (de) 2007-08-16 2007-08-16 Herstellung und Verwendung von Extrakten oder Extraktivstoffen aus Piper cubeba L. als wirksame Bestandteile in einem Medikament zur Behandlung von Krebserkrankungen.
EP08783450A EP2182966B1 (de) 2007-08-16 2008-08-15 Verwendung von extrakten oder extraktivstoffen aus piper cubeba l. als wirksame bestandteile in einem medikament zur behandlung von krebserkrankungen
PCT/CH2008/000350 WO2009021347A1 (de) 2007-08-16 2008-08-15 Verwendung von extrakten oder extraktivstoffen aus piper cubeba l. als wirksame bestandteile in einem medikament zur behandlung von krebserkrankungen

Publications (1)

Publication Number Publication Date
PL2182966T3 true PL2182966T3 (pl) 2013-01-31

Family

ID=38668948

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08783450T PL2182966T3 (pl) 2007-08-16 2008-08-15 Zastosowanie ekstraktów lub substancji ekstrahowanych z Piper cubeba L. jako składników czynnych leku do leczenia chorób nowotworowych

Country Status (14)

Country Link
US (3) US8404286B2 (pl)
EP (1) EP2182966B1 (pl)
JP (1) JP5378379B2 (pl)
KR (1) KR20100089815A (pl)
CN (1) CN102065875B (pl)
AU (1) AU2008286636B2 (pl)
BR (1) BRPI0815188A2 (pl)
CA (1) CA2696499A1 (pl)
CH (1) CH698627B1 (pl)
ES (1) ES2392310T3 (pl)
PL (1) PL2182966T3 (pl)
RU (1) RU2470657C2 (pl)
WO (1) WO2009021347A1 (pl)
ZA (1) ZA201000959B (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI472333B (zh) * 2008-06-26 2015-02-11 Piramal Entpr Ltd 治療口腔念珠菌病之口服草本組成物
WO2011075801A1 (pt) * 2009-12-21 2011-06-30 Acef S.A. Cubebina, lignana dibenzilbutirolactólica, seus derivados semi-sintéticos e sintéticos, bem como outras lignanas e neolignanas como agente vasodilatador na terapia da disfunção erétil
WO2014027857A1 (ko) * 2012-08-16 2014-02-20 부산대학교 산학협력단 알파-이소-쿠베벤 또는 알파-이소-쿠베베놀을 유효성분으로 포함하는 감염성 및 염증성 질환의 예방 또는 치료용 조성물
WO2014086379A1 (en) 2012-12-03 2014-06-12 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences Ag Lignan compositions
FR3085846B1 (fr) * 2018-09-13 2022-01-21 Robertet Sa Utilisation d’extrait de p.nigrum, p. cubeba et/ou s. therebentifolius dans des preparations cosmetiques pour favoriser la pousse des poils
JP7197908B2 (ja) * 2019-03-04 2022-12-28 株式会社ナチュファルマ琉球 骨減少性疾患の予防及び／又は治療用組成物
CN114574286B (zh) * 2022-02-18 2024-03-22 中国热带农业科学院香料饮料研究所 一种具有抗炎活性的胡椒精油及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9815177D0 (en) 1998-07-13 1998-09-09 King S College London Treatment of skin disorders
JP3091962B2 (ja) * 1998-09-25 2000-09-25 アルプス薬品工業株式会社 テストステロン−５α−レダクターゼ阻害剤
WO2003047551A1 (en) * 2001-11-29 2003-06-12 Penwest Pharmaceutical Company Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
BR0201237A (pt) 2002-03-25 2003-12-02 Fundacao De Amparo A Pesquisa Processo de obtenção de lignanas dibenzilbutirolactÈnicas, processo de obtenção de derivados sintéticos de lignanas ostentando atividades quimioprofilática e terapêutica antichagásica
US20030228383A1 (en) * 2002-06-06 2003-12-11 J.B. Chemicals & Pharmaceuticals, Ltd. Herbal cough formulations and process for the preparation thereof
JP2004160165A (ja) * 2002-09-17 2004-06-10 Pauretsuku:Kk 生薬成分製剤の造粒方法
DE60220958T2 (de) * 2002-12-30 2008-04-10 Council Of Scientific And Industrial Research Entwicklung einer hustenstillenden und rachenschmerzlindernden formulierung aus kräutern
JP4319417B2 (ja) * 2003-01-30 2009-08-26 学校法人近畿大学 メラニン産生不全症治療剤
US20070248693A1 (en) * 2003-08-02 2007-10-25 Elizabeth Mazzio Nutraceutical composition and method of use for treatment / prevention of cancer

Also Published As

Publication number Publication date
US20160193272A1 (en) 2016-07-07
EP2182966A1 (de) 2010-05-12
CA2696499A1 (en) 2009-02-19
ES2392310T3 (es) 2012-12-07
AU2008286636A1 (en) 2009-02-19
EP2182966B1 (de) 2012-08-08
ZA201000959B (en) 2010-10-27
CN102065875A (zh) 2011-05-18
US20130251826A1 (en) 2013-09-26
AU2008286636B2 (en) 2013-10-24
KR20100089815A (ko) 2010-08-12
RU2010109750A (ru) 2011-09-27
CN102065875B (zh) 2013-07-17
US9248156B2 (en) 2016-02-02
JP2010536718A (ja) 2010-12-02
US8404286B2 (en) 2013-03-26
CH698627B1 (de) 2009-09-15
RU2470657C2 (ru) 2012-12-27
JP5378379B2 (ja) 2013-12-25
WO2009021347A1 (de) 2009-02-19
BRPI0815188A2 (pt) 2015-03-31
US20110135760A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
IL255752B (en) Compounds, pharmaceutical preparations containing the same uses for the treatment of cardiovascular disease, inflammatory diseases and cancer
HK1224200A1 (zh) 用於治療胰腺癌的藥物
IL196470A (en) Antagonist antibody for cancer treatment
EP1994181A4 (en) IDENTIFICATION AND USE OF NOVOPEPTIDES FOR THE TREATMENT OF CANCER
HK1114350A1 (en) An extract for preventing or treating thrombotic diseases
EP1985302A4 (en) DRUGS FOR TUMOR THERAPY AND ITS USE
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
IL216967B (en) The history of 17-hydroxy-17-pentafluoroethyl-astra-9,4 (10)-diene-11-aryl and their use for the treatment of diseases
ZA201000959B (en) The use of extracts or materials extracted from Piper cubeba L. as an effective component in a drug for the treatment of cancer diseases
IL201562A0 (en) Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases
SI2234631T1 (sl) Spojine in postopki za zdravljenje ĺ˝ilne bolezni
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
GB2443588B (en) A pharmaceutical composition useful for the treatment of prostate cancer
ZA200806949B (en) Medicinal formulation for the treatment for hepatitis C
EP2005964A4 (en) MEDICAMENT FOR TREATING HYPERPHOSPHATEEMIA AND PREPARATION METHOD THEREOF
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
PL2046390T3 (pl) Ekstrakt z siemienia lnianego jako lek do stosowania do oka
IL226362A0 (en) compounds, and methods for treating cancer
ZA200805522B (en) Dioxoiane dérivates for the treatment of cancer
GB0602857D0 (en) The treatment of sialorrhoea
GB0606322D0 (en) The medical eradicator
GB0616532D0 (en) Molecular methods for the treatment of disease
AU2013204964B2 (en) Activin-actriia antagonists and uses for treating or preventing breast cancer
BRPI0602549B1 (pt) gaveta classificadora de medicamentos e procedimento de fabricação de gaveta classificadora de medicamentos.